Regression til normo albuminuri (< 30 mg/ dag) forekom hyppigere i gruppen, der fik Aprovel 300 mg (34%) end i placebogruppen (21%).
Regression to normoalbuminuria (< 30 mg/ day) was more frequent in the Aprovel 300 mg group (34%) than in the placebo group (21%).